#United States #Sarasota #Florida Cancer #Oncologist #Radiation Oncology

Strengthening Care with New Experts at Florida Cancer Specialists

Florida Cancer Specialists & Research Institute (FCS) has made significant strides in its mission to provide outstanding cancer care with the recent addition of two esteemed medical professionals, Dr. Bhanu Visvalingam and Dr. John Bollinger. This expansion of expertise is aimed at enhancing patient access to innovative therapies and comprehensive treatment options across their statewide practice.

New Additions to the Team

Dr. Bhanu Visvalingam, a board-certified medical oncologist and hematologist, is set to provide care at various locations, including FCS's Lake Mary Cancer Center, and the facilities in Deland and Orange City. His impressive background includes completing his medical degree from Boston University School of Medicine and undergoing residency training in internal medicine at Winthrop University Hospital, New York. Dr. Visvalingam further advanced his expertise with a fellowship in hematology and oncology at New York University’s Grossman Long Island School of Medicine.

Dr. John Bollinger joins as a radiation oncologist, bringing a wealth of knowledge gained from his medical education at the Medical College of Georgia and his residency in radiation oncology at the University of Oklahoma Health Sciences Center. He will be serving patients primarily at the FCS Sarasota Downtown clinic and collaborating with the Sarasota Memorial Radiation Oncology team.

Commitment to Innovative Care

FCS emphasizes the importance of research and innovation in clinical oncology. Dr. Wenk, Assistant Managing Physician, highlighted Dr. Visvalingam’s strong credentials, noting his involvement in clinical research aimed at developing advanced cancer treatment therapies. FCS, with its long-standing reputation, provides access to a broad range of clinical trials, facilitating the opportunity for patients to partake in groundbreaking treatments and therapies that may not be available elsewhere.

FCS’s CEO Nathan H. Walcker remarked on the growing community demands in Sarasota County and reaffirmed the organization’s commitment to attracting highly qualified cancer experts like Dr. Bollinger and Dr. Visvalingam to cater to the evolving needs of their patients. This move not only aims to enhance the quality of care but also ensures accessibility to top-tier oncology services in the region.

Leading in Cancer Care

Founded in 1984, Florida Cancer Specialists has fostered a national reputation for excellence, driven by a core mission to provide compassionate patient care combined with advanced clinical research. FCS is recognized for being a leading private oncology group in Florida, participating in numerous clinical trials that have driven the development of many recently approved cancer drugs in the U.S.

FCS’s commitment to remaining at the forefront of cancer treatment is reflected in its use of cutting-edge technologies and innovative therapies including genomic-based treatment, immunotherapy, and targeted therapies.

For those interested in learning more about the radiation oncology services available at FCS, additional details can be accessed through their website at FCS Radiation Therapy Treatment. With these recent additions to their team, FCS is more equipped to face the challenges of cancer care and fulfill its dedication to excellence in patient outcomes.

In conclusion, the Florida Cancer Specialists & Research Institute is reinforcing its mission to provide exceptional cancer care while adapting to the needs of a rapidly growing community. The integration of Dr. Visvalingam and Dr. Bollinger into their team signals an important step towards enhancing the quality of care provided to patients across Florida.